 |
|
Apoptotic Inhibition of Head and Neck Squamous Cell Carcinoma Cells by Tumor Necrosis Factor 
Kenneth B. Briskin, MD;
Catherine Fady, PhD;
Marilene Wang, MD;
Alan Lichtenstein, MD
Arch Otolaryngol Head Neck Surg. 1996;122(5):559-563.
Abstract
| |
Objectives
To evaluate the effect and mechanism of action of tumor necrosis factor  (TNF-) on head and neck squamous cell carcinoma (HNSCC) cell lines. Specifically, to find out whether TNF- induces apoptotic (programmed) cell death.
Design
Cytotoxicity and kinetics were evaluated through the use of a methylene blue colorimetric assay. The mechanism of cell death was evaluated through gel electrophoresis of extracted DNA, double-stranded DNA fragmentation, and Hoechst 33342–propidium iodide double staining.
Target Cells
Four HNSCC cell lines were investigated: UMSCC-1, UMSCC-8, UMSCC-19, and CAL-27.
Results
Tumor necrosis factor at a concentration of 10 000 U/mL induced cytotoxic effects in all four cell lines with varying sensitivities. Significant cytotoxic effects required 3 to 4 days of exposure to TNF-. Further experiments demonstrated that TNF- induced double-stranded DNA fragmentation of targets, which preceded the detection of actual cytotoxic effects. Treated HNSCC cell lines had their DNA fragmented into a ladder pattern of endonucleolytic cleavage of multiples of 180 to 200 base pairs, consistent with apoptosis. Propidium iodide–Hoechst 33342 double staining confirmed that TNF-–induced nuclear alterations precede permeabilization of the plasma membrane, supporting cell death in these tumor cells by apoptosis.
Conclusions
Tumor necrosis factor exposure results in variable cytotoxic reactions in HNSCC cell lines, with DNA fragmentation preceding significant cell death. The mechanism of cell death is apoptosis, with typical morphological features. Further studies are needed to better elucidate the role of TNF- in the treatment of in vivo HNSCC.
(Arch Otolaryngol Head Neck Surg. 1996;122:559-563)
Author Affiliations
From the Division of Head and Neck Surgery (Drs Briskin and Wang) and the Department of Medicine (Drs Fady and Lichtenstein), University of California, Los Angeles, School of Medicine, and the Veterans Affairs Medical Center, West Los Angeles. Dr Briskin is now with the Section of Otolaryngology, Yale University School of Medicine, New Haven, Conn.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Proliferative and Apoptotic Responses in Cancers With Special Reference To Oral Cancers
Kamer et al.
CROBM 1999;10:58-78.
ABSTRACT
| FULL TEXT
|
